The Adaptor Molecule Signaling Lymphocytic Activation Molecule (SLAM)-associated Protein (SAP) is Essential in Mechanisms Involving the Fyn Tyrosine Kinase for Induction and Progression of Collagen-induced Arthritis
Overview
Authors
Affiliations
Signaling lymphocytic activation molecule-associated protein (SAP) is an Src homology 2 domain-only adaptor involved in multiple immune cell functions. It has also been linked to immunodeficiencies and autoimmune diseases, such as systemic lupus erythematosus. Here, we examined the role and mechanism of action of SAP in autoimmunity using a mouse model of autoimmune arthritis, collagen-induced arthritis (CIA). We found that SAP was essential for development of CIA in response to collagen immunization. It was also required for production of collagen-specific antibodies, which play a key role in disease pathogenesis. These effects required SAP expression in T cells, not in B cells. In mice immunized with a high dose of collagen, the activity of SAP was nearly independent of its ability to bind the protein tyrosine kinase Fyn and correlated with the capacity of SAP to promote full differentiation of follicular T helper (TFH) cells. However, with a lower dose of collagen, the role of SAP was more dependent on Fyn binding, suggesting that additional mechanisms other than TFH cell differentiation were involved. Further studies suggested that this might be due to a role of the SAP-Fyn interaction in natural killer T cell development through the ability of SAP-Fyn to promote Vav-1 activation. We also found that removal of SAP expression during progression of CIA attenuated disease severity. However, it had no effect on disease when CIA was clinically established. Together, these results indicate that SAP plays an essential role in CIA because of Fyn-independent and Fyn-dependent effects on TFH cells and, possibly, other T cell types.
SLAM Associated Protein Signaling in T Cells: Tilting the Balance Toward Autoimmunity.
Gartshteyn Y, Askanase A, Mor A Front Immunol. 2021; 12:654839.
PMID: 33936082 PMC: 8086963. DOI: 10.3389/fimmu.2021.654839.
Zhong M, Lu Y, Qian J, Zhu Y, Dong L, Zahn A J Exp Med. 2020; 218(3).
PMID: 33237304 PMC: 7694575. DOI: 10.1084/jem.20200756.
T-B Lymphocyte Interactions Promote Type 1 Diabetes Independently of SLAM-Associated Protein.
Bonami R, Nyhoff L, McNitt D, Hulbert C, Felton J, Kendall P J Immunol. 2020; 205(12):3263-3276.
PMID: 33199538 PMC: 7725913. DOI: 10.4049/jimmunol.1900464.
Takahashi D, Hoshina N, Kabumoto Y, Maeda Y, Suzuki A, Tanabe H EBioMedicine. 2020; 58:102913.
PMID: 32711255 PMC: 7387783. DOI: 10.1016/j.ebiom.2020.102913.
Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk.
Witalis M, Chang J, Zhong M, Bouklouch Y, Panneton V, Li J Blood Adv. 2020; 4(5):868-879.
PMID: 32130407 PMC: 7065475. DOI: 10.1182/bloodadvances.2019001114.